Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets
Clinical Immunology · 2026-12 · 288 · 110787
DOI: 10.1016/j.clim.2026.110787 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Immunology, 2026-12. Verfasst von Xiaoli Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research …. Die Arbeit nennt 115 Literaturangaben.
Themen: Sepsis
Abstract (Originalsprache)
Despite advances in critical care, sepsis remains a leading cause of mortality driven by a profoundly dysregulated host immune response. Increasingly, defective efferocytosis-the fundamental physiological process for clearing dead cells-has been identified as a critical catalyst in sepsis pathophysiology. Under normal conditions, efferocytosis resolves inflammation and maintains tissue homeostasis. However, during sepsis, the efferocytotic capacity of phagocytes is severely paralyzed. This clearance failure results in a massive accumulation of apoptotic and necrotic cellular debris within the tissue microenvironment, triggering an unabated release of damage-associated molecular patterns (DAMPs). Consequently, this substrate overload sustains a self-amplifying inflammatory storm that accelerates tissue injury and precipitates multiple organ failure. In this review, we dissect the diverse modalities of programmed cell death in sepsis and map the subsequent breakdown of the core, multi-step efferocytotic machinery. We systematically explore the molecular basis of efferocytosis failure across distinct organ-specific complications, including acute lung injury, sepsis-associated encephalopathy, acute kidney injury, and septic cardiomyopathy. Finally, we evaluate emerging targeted therapies aimed at restoring efferocytotic efficiency, highlighting a crucial conceptual shift from primarily suppressing inflammation to actively promoting its resolution and repairing host immunity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Experiment Center, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China; Tianjin Key Laboratory of…
- North Hospital Emergency Department, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China.
- Department of Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China; National Clinical Research Center for Chinese Medicine, Tianjin, China.
Zitieren
APA
Qin, X., Zhong, A., Zhou, Z., Song, X., Song, Y., & Xu, S. (2026). Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets. Clinical Immunology, 288, 110787. https://doi.org/10.1016/j.clim.2026.110787
Vancouver
Qin X, Zhong A, Zhou Z, Song X, Song Y, Xu S. Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets. Clinical Immunology. 2026;288:110787. doi:10.1016/j.clim.2026.110787
BibTeX
@article{Qin2026,
author = {Qin, Xiaoli and Zhong, Aiqin and Zhou, Zimeng and Song, Xiaoli and Song, Yiqun and Xu, Shixin},
title = {Sepsis-associated efferocytosis deficiency: Molecular mechanisms and novel therapeutic targets},
journal = {Clinical Immunology},
year = {2026},
volume = {288},
pages = {110787},
doi = {10.1016/j.clim.2026.110787}
}
EUVIMED